On Monday, Chinese President Xi Jinping presided over a meeting with Alibaba co-founder Jack Ma and other prominent ...

China is not ready for war, according to a contentious report from a US think tank, which claims the main motivation for the ...

India will once again head into another ICC event being favourites to lift the title. However, the Rohit Sharma-led side has been jolted by the absence of their ace speedster Jasprit Bumrah for the ...

Acquisition includes abelacimab, a Factor XI-inhibiting monoclonal antibody in development for stroke prevention in patients ...

Indian cricket team head coach Gautam Gambhir spoke on several aspects following the side’s 3-0 win over England in the ODI ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Ahead of the final Merseyside derby at Goodison Park, reminisce over one of the most memorable clashes between Everton and ...

Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.

Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...

Novartis has agreed to acquire Boston-based clinical-stage biopharmaceutical company Anthos Therapeutics for an upfront ...

Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...